News
In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, shares best practices for reducing greenhouse gas emissions ...
July 7 – With a 90-day negotiating period on country-specific US tariffs is set to expire on July 9, Trump enacts a multitude ...
In the second part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker ...
A JAMA Network Open study reveals that patients with private insurance can face monthly costs nearing $600 after a cancer ...
In the first part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...
In the final part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, discusses the potential repercussions of telehealth companies selling GLP-1s.
A formal trade agreement between the US and EU introduces a 15% tariff on most EU exports, including pharmaceuticals, ...
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, dives into the metrics pharma companies can track today in order ...
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, explains the meaning behind Scope 3 emissions, including why they ...
Kevin Chinn, vice president and head of the cell & gene therapy service line at Cencora, outlines why early planning, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results